Clinical and experimental studies have shown endothelial dysfunction improvement after administration of BH4 in patients with hypercholesterolemia [57], and increased total biopterin and BH4 levels in aorta along with endothelial dysfunction improvement in apoE-deficient mice after antioxidant treatment [58]. This evidence concerns the gene APOE and familial hypercholesterolemia.